AR124709A2 - RECOMBINANT VON WILLEBRAND FACTOR (rVWF) USEFUL IN VON WILLEBRAND DISEASE OR HEMOPHILIA A - Google Patents

RECOMBINANT VON WILLEBRAND FACTOR (rVWF) USEFUL IN VON WILLEBRAND DISEASE OR HEMOPHILIA A

Info

Publication number
AR124709A2
AR124709A2 ARP220100161A ARP220100161A AR124709A2 AR 124709 A2 AR124709 A2 AR 124709A2 AR P220100161 A ARP220100161 A AR P220100161A AR P220100161 A ARP220100161 A AR P220100161A AR 124709 A2 AR124709 A2 AR 124709A2
Authority
AR
Argentina
Prior art keywords
von willebrand
rvwf
hemophilia
factor
useful
Prior art date
Application number
ARP220100161A
Other languages
Spanish (es)
Inventor
Peter Turecek
Friedrich Scheiflinger
Bruce Ewenstein
Wing Yen Wong
Tobias M Suiter
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of AR124709A2 publication Critical patent/AR124709A2/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Métodos para tratar los trastornos de la coagulación, entre los que se incluyen la hemofilia y la enfermedad de von Willebrand, que comprenden la administración del factor de von Willebrand, solo o en combinación con el factor VIII. Reivindicación 1: Un factor de von Willebrand recombinante (rVWF) para uso en un método para tratar la enfermedad de von Willebrand o la hemofilia A en un sujeto que lo necesita, caracterizado porque el rVWF no está modificado con un polímero soluble en agua, y el rVWF es una composición de multímeros de VWF de alto peso molecular que comprende al menos un 20% de decámeros de VWF o multímeros de orden superior.Methods of treating coagulation disorders, including hemophilia and von Willebrand disease, involving administration of von Willebrand factor, alone or in combination with factor VIII. Claim 1: A recombinant von Willebrand factor (rVWF) for use in a method of treating von Willebrand disease or hemophilia A in a subject in need thereof, characterized in that the rVWF is not modified with a water-soluble polymer, and rVWF is a high molecular weight VWF multimer composition comprising at least 20% VWF decamer or higher order multimers.

ARP220100161A 2011-06-10 2022-01-27 RECOMBINANT VON WILLEBRAND FACTOR (rVWF) USEFUL IN VON WILLEBRAND DISEASE OR HEMOPHILIA A AR124709A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161495884P 2011-06-10 2011-06-10

Publications (1)

Publication Number Publication Date
AR124709A2 true AR124709A2 (en) 2023-04-26

Family

ID=78803844

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP200100969A AR118608A2 (en) 2011-06-10 2020-04-06 TREATMENT OF BLEEDING DISORDERS BY ADMINISTRATION OF A RECOMBINANT VON WILLEBRAND FACTOR (vWF)
ARP220100161A AR124709A2 (en) 2011-06-10 2022-01-27 RECOMBINANT VON WILLEBRAND FACTOR (rVWF) USEFUL IN VON WILLEBRAND DISEASE OR HEMOPHILIA A

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP200100969A AR118608A2 (en) 2011-06-10 2020-04-06 TREATMENT OF BLEEDING DISORDERS BY ADMINISTRATION OF A RECOMBINANT VON WILLEBRAND FACTOR (vWF)

Country Status (1)

Country Link
AR (2) AR118608A2 (en)

Also Published As

Publication number Publication date
AR118608A2 (en) 2021-10-20

Similar Documents

Publication Publication Date Title
AR086904A1 (en) TREATMENT OF COAGULATION DISORDERS THROUGH THE ADMINISTRATION OF VON WILLEBRAND RECOMBINING FACTOR (VWF)
CY1113869T1 (en) LYophilized VWF Recombinant Formulations
ES2552651T3 (en) Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases
CY1121819T1 (en) HUMAN RPE CELL PHARMACEUTICAL PREPARATIONS AND USES THEREOF
ES2722209T3 (en) Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
BR112015030428A2 (en) fragrance composition
ECSP13012411A (en) PHARMACEUTICAL COMPOSITIONS INCLUDING 4-AMINO-5-FLUORO-3- LACTATE MONOHIDRATE [6- (4-METHYL-PIPERAZIN-1-IL) -1H-BENCIMIDAZOL-2-IL] -1H-QUINOLIN-2-ONA
CY1118396T1 (en) THERAPEUTIC ANALYTICAL COMPOSITIONS
BR112013032928A2 (en) "peptide-binding maytansinoid derivatives and conjugates thereof, pharmaceutical composition comprising and use thereof"
ES2530624T3 (en) Adhesive compositions
CU23814A3 (en) INTRAVENOUS EMULSION OF BUTILFTALIDA AND APPLICATION OF THE SAME
UY33183A (en) INHIBITING COMPOUNDS OF VIRUS FLAVIVIRIDAE, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT
SV2010003721A (en) DOUBLE LAYER SURGICAL PROTESIS FOR THE REPAIR OF SOFT FABRICS
AR060784A1 (en) BINARY MIXING OF HIALURONIC ACID AND ITS THERAPEUTIC USE
BR112015012366A8 (en) cxcr7 antagonists, their use, pharmaceutical composition, as well as methods for detecting high levels of cxcr7 in a sample and for imaging a tumor, organ, or tissue
AR056291A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TROMBOSIS TREATMENT
BR112014026616A2 (en) polymer-based dialysate
AR066134A1 (en) PEPTIDE MIXTURE AS A WINE STABILIZER
BR112015028040A2 (en) acrylate-derived main chain-containing polymer, methods for preparing polymers, pharmaceutical formulations and methods for increasing the solubility of a drug
ES2721400T3 (en) Diclofenac composition
BRPI0808599A2 (en) "nucleic acid, vaccine, pharmaceutical composition, use of a nucleic acid and method for stimulating an immunoresponse versus a t-cell epitope"
MX2022005664A (en) Recombinant mva viruses for intratumoral and/or intravenous administration for treating cancer.
BR112018009028A8 (en) polymer mixtures for use in multilayer structure and multilayer structures comprising the same
CO2020001322A2 (en) Treatment of gastrointestinal bleeding in patients with severe von willebrand disease by administration of recombinant vwf
BR112015023793A2 (en) Therapy Compositions and Methods for Inducing Factor VII Replacement Immune Tolerance in Individuals with Hemophilia a